Seeking Alpha EN

Myomo Non-GAAP EPS of -$0.37 misses by $0.28, revenue of $11.4M beats by $1M

Mar 09, 2026 &03130909202631; 20:13 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

→

Neutral impact

Sentiment score: -15/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Myomo reported Q3 revenue of $11.4M, beating expectations by $1M, but posted a non-GAAP EPS of -$0.37, missing estimates by $0.28. The company demonstrates revenue growth momentum but continues to face profitability challenges.

AI CONFIDENCE

65% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

⇅

MYO

MYOStock

High volatility expected

Mixed earnings results with revenue beat offset by significant EPS miss; market reaction likely depends on forward guidance and path to profitability

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Monitor Myomo's guidance and cash position closely. The revenue beat is encouraging, but persistent losses warrant caution. Consider waiting for clarity on path to profitability before establishing long positions.

KEY SIGNALS

Revenue beat indicates strong demand for productsSignificant EPS miss suggests operational inefficiencies or high R&D spendingContinued losses raise concerns about cash burn and sustainabilityGrowth trajectory positive but profitability timeline unclear

SECTORS INVOLVED

HealthcareMedical DevicesBiotechnology

Analysis generated on Mar 10, 2026 at 00:28 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Myomo Non-GAAP EPS of -$0.37 misses by $0.28, revenue of $11.4M beats by $1M

RELATED INTELLIGENCE